Genitourinary Cancer

Top Story

Pembrolizumab plus axitinib prolongs survival in advanced renal cell carcinoma

May 29, 2020

Read the Perspective from Kai Tsao, MD

FDA News

FDA approves oncology, hematology therapies

HemOnc Today, May 25, 2020
The FDA approved several therapies for oncology or hematology indications.
FDA News

FDA grants breakthrough therapy status to two cancer therapies

HemOnc Today, May 25, 2020
The FDA granted breakthrough therapy status to two cancer therapies. One designation applies to use of mobocertinib (TAK-788, Takeda) by patients with metastatic…
FDA News

FDA grants fast track status to several agents

HemOnc Today, May 10, 2020
The FDA granted fast track designation to several therapies in development for hematology or oncology indications.
More Headlines »